The aetiology for an increasing incidence of hypertensive cardiovascular disease amongst Africans in southern Africa is unclear. Hypertension may be induced by inadequate release of L-arginine-derived nitric oxide impairing vascular tone regulation. In addition, asymmetric dimethylarginine (ADMA) is associated with cardiovascular disease. We compared profiles of L-arginine in African and Caucasian men of similar age with cardiovascular risk factors. We studied 163 Caucasian and 132 African men, respectively, (20 to 70 years) measuring serum L-arginine, ADMA, creatinine, urea, symmetric dimethylarginine (SDMA) and blood pressure. L-arginine levels were significantly lower, whereas blood pressure and pulse wave velocity were significantly higher in African men. Simple linear regression showed ADMA more strongly associated with L-arginine in Caucasians (r ¼ 0.59 vs 0.19), whereas association of SDMA with L-arginine was significant only in Caucasians (r ¼ 0.43 vs 0.001). The stronger association of L-arginine with ADMA in Caucasian men was confirmed by multiple regression analysis (b ¼ 0.46 vs 0.25). Our findings show that the relationship of cardiovascular risk factors with serum L-arginine and some of its catabolites is different in African and Caucasian men and that this may be associated with a relatively higher prevalence of hypertension in African men.
INTRODUCTION
Hypertension, cardiovascular disease and cerebral infarction are frequently the consequence of endothelial dysfunction. Endothelium releases a variety of signaling molecules, which affect processes such as diapedesis and inflammation and regulate the vascular tone via factors such as nitric oxide (NO) 1,2 and endothelin. 3 These act on smooth muscle to dilate or constrict blood vessels, thereby having a significant role in moderating increases in blood pressure, peripheral resistance and the development of hypertension.
Although L-arginine is involved in nutrition, modulating obesity in genetically obese rats and humans with type 2 diabetes, it is more significant as the limiting substrate for the enzyme that produces NO in the vasculature: endothelial NO synthase.
Stimuli, such as shear stress, stimulate receptors on endothelial cell surfaces initiating signaling pathways, which activate endothelial NO synthase leading to a release of NO into the vasculature. 7 Deficient bioavailability of NO impairs endothelialfunction, 8 including endothelium-dependent vasodilation, which characterises essential hypertension. 9 Endogenous derivates of L-arginine competitively inhibit endothelial NO synthase, so that the bioavailability of NO in the vasculature is not solely dependent on the availability of L-arginine. 10 These derivatives are asymmetric dimethylarginine (ADMA) and monomethylarginine, of which only the former is produced in pathophysiologically relevant amounts. 11 Symmetric dimethylarginine (SDMA) does not inhibit endothelial NO synthase, but it interferes with Larginine uptake via the y þ carrier into the endothelial cells. 12 Both ADMA and SDMA are risk markers for vascular disease, 13 --18 while SDMA is also reported to predict renal damage. 19 L-arginine supplementation improves the reduced vasodilatory response in offspring of hypertensive patients and in normotensive patients with familial essential hypertensive histories, suggesting that a genetic predisposition to essential hypertension involves a defect in NO generation. 9 Various aspects of the effect of L-arginine augmentation have been studied in human subjects, 20 --22 in animal experiments 23, 24 and in tissue culture. 25 However, there is a dearth of epidemiological studies investigating ethnic differences in L-arginine utilisation. The prevalence of hypertension in black Americans and black South Africans is significantly greater than in those of ethnic Caucasian origin. 26 --32 Although conventional cardiovascular risk markers are expressed in both population subgroups, these markers do not correspond with the prevalence of hypertension and cardiovascular disease in black South Africans to the same degree as they do in Caucasians. 31,33 --36 Profiles of several other cardiovascular risk factors in the two ethnic groups also differ. For example, Melikian et al. 33 reported that in a small study on black Africans (n ¼ 30) living in Europe, ethnicity predicted serum concentrations of ADMA. A decrease in the relative availability of NO may diminish endothelial function, potentially contributing to the higher prevalence of hypertension and cardiovascular disease. 37 We investigated this possibility further by examining the relationships between L-arginine, the inhibitors of its transport and NO production, SDMA and ADMA, respectively, and other cardiovascular risk factors in two male cohorts of South Africans: Africans and Caucasians.
METHODS

Study design and subject selection
The effect of ethnicity on L-arginine, the metabolites derived from it and cardiovascular function was studied in 345 male volunteers (20 --70 years) from Africans and Caucasians living in urban areas of the North West Province of South Africa, using data collected during the South African study regarding the influence of sex, age and ethnicity on insulin sensitivity and cardiovascular function (the SAfrEIC study). Exclusion criteria were previous diagnosis of any serious chronic disease (except hypertension), such as diabetes (n ¼ 2), or other symptoms indicating illness in individuals, such as headache or fever, renal and hepatic dysfunction (jaundice). In addition, for this exploratory study, all HIVinfected individuals (n ¼ 53) were excluded. None of the Africans used antihypertensive medication, whereas 22% of the Caucasians used medication. This study was approved by the Ethics Committee of the North-West University (Potchefstroom campus), in line with the Declaration of Helsinki revised in 2008. Informed written consent was obtained from all participants after procedures had been explained to them in their home language.
Organisational procedures
Participants underwent a clinical examination within the Metabolic Unit of the Potchefstroom campus starting at 0700 hours. For each individual, anthropometric measurements were taken and basic health and demographic questionnaires were completed. A registered nurse took a fasting blood sample (brachial vein) followed by cardiovascular measurements. After these procedures were completed, each participant was given a full breakfast and financial compensation for travel expenses. Before leaving, they also received feedback on their health status and were referred to their local physician, clinic or hospital if any irregularities (for example, in blood pressure) were encountered.
Biochemical analyses
Participants fasted overnight before blood samples were taken to provide serum and plasma aliquots, which were separated and stored at À80 1C. A LifeScan Surestep Blood Glucose Monitoring System (LifeScan, Inc., Milputas, CA, USA) was used to measure capillary blood glucose as a screen for diabetes mellitus. A Konelab auto-analyser (Thermo Fisher Scientific Oy, Vantaa, Finland) was used to determine lipograms, serum blood glucose, creatinine, C-reactive protein (hsCRP) and g-Glutamyl transferase. Renal function was assessed using the Cockcroft --Gault formula 38 adjusted for body surface area, to determine the glomerular filtration rate (GFR). Plasma cotinine was measured by enzyme immunoassay (Diagnostic Reagents, Inc., Sunnyvale, CA, USA) using a Roche modular analyser (Roche, Basel, Switzerland). An immunoenzymometric assay (ST AIA-PACK IRI kit, cat. No. 025260, Tosoh Corp., Tokyo, Japan) was used for insulin analyses. The homeostasis model index assessment (HOMA) was calculated as the product of the fasting serum concentrations of insulin and glucose divided by 22.5. Immediately after blood sampling, HIV status was determined with the First Response test haemagglutination assay (PMC Medical, Daman, India) and confirmed with the Pareeshak test (BHAT Bio-tech, Bangalore, India). Mass spectrometric determinations of L-arginine, ADMA and SDMA were performed as described elsewhere by using a fully validated high throughput LC-MS/MS assay, which is commercially available (DLD Diagnostika, Hamburg, Germany). 39, 40 Reactive oxygen species was measured using a spectrophotometric assay, where 1.0 mg l À1 H 2 O 2 represents one unit of reactive oxygen species. 41 Anthropometric measurements
Waist circumferences, height and weight were measured according to the standard protocols. 42 A Holtain metal tape was used to measure circumferences, whereas height was measured to the nearest 0.1 cm with the Invicta Stadiometer (IP 1465, Invicta Plastics Ltd, Leicester, UK). A digital scale (Precision Health Scale; A & D Company, Tokyo, Japan) was used to weigh individuals to the nearest 0.1 kg.
Cardiovascular measurements
Following a 10 min rest period in a seated position, the OMRON HEM-757 apparatus (Omron Healthcare, Kyoto, Japan) was used to measure diastolic and systolic blood pressures (BP cuff on left arm). This was repeated after another 5 min at rest. Noninvasively accessible superficial pulses in a musculo-elastic mixed arterial segment (carotid-dorsalis pedis) were used to measure pulse wave velocity with the Complior SP device (Artech Medical, Pantin, France) on the left side of each subject. Pulse wave velocity was measured in all participants in the supine position by the same two observers. A Finometer (FMS, Amsterdam, the Netherlands) was used to measure arterial compliance (Cw).
Statistical analyses
Statistica, version 10 (StatSoft, Inc., Tulsa, OK, USA) was used in all statistical analysis. The distribution of measurements for waist circumference, insulin, g-Glutamyl transferase and the homeostasis model index assessment were normalized by logarithmic transformation. The central tendency and spread of these variables were represented by the geometric mean and the 5th and 95th percentile intervals. We compared means and proportions by a standard t-test and the 5th and 95th percentile intervals. We investigated associations between L-arginine and cardiovascular variables using single and multiple linear regressions and identified covariates using a forward stepwise regression procedure. P-values were set at 0.13 for significance to enter and stay in the models. Independent variables included age, body mass index (BMI), diastolic blood pressure, serum creatinine, serum urea and SDMA. . A total of 32.5% and 14.5% of African and Caucasian men, respectively, were hypertensive (Po0.001).
RESULTS
Characteristics of participants
Adjusted analysis
In exploratory analyses (Figure 1) , Cw, serum urea, ADMA and SDMA were plotted by quartiles of L-arginine, with adjustments applied for age and BMI. By doing so, the significant positive associations between ADMA (P for trend, 0.001) and SDMA (P for trend,0.001) with L-arginine were evident in Caucasian men, but absent in African men. No correlation existed between Cw and L-arginine, or between serum urea and L-arginine. However, a tendency existed for both in the African men only (P for difference between the lowest and highest quartiles, 0.003 and 0.034, respectively).
Linear regression analyses
We investigated unadjusted correlations of arginine with markers of cardiovascular dysfunction. L-arginine correlated significantly with age in both Africans (r ¼ À0.20, P ¼ 0.022) and Caucasians (r ¼ À0.15, P ¼ 0.045). However, L-arginine did not correlate significantly with potential confounders, such as BMI or waist circumference in Africans (r ¼ 0.018, P ¼ 0.84 and r ¼ À0.08, P ¼ 0.348, respectively) and Caucasians (r ¼ 0.035, P ¼ 0.64 and r ¼ 0.15, P ¼ 0.095, respectively). As shown in Table 2 , L-arginine correlated strongly with ADMA in Caucasian men and weakly in African men. The correlation with Cw was significant in African men only, whereas significant associations with SDMA and reactive oxygen species were evident only in Caucasian men.
Partial regression analyses After adjusting for age and BMI (Table 3) , L-arginine correlated with Cw (r ¼ 0.20, P ¼ 0.012), urea (r ¼ À0.18, P ¼ 0.031), ADMA (r ¼ 0.58, Po0.001) and SDMA (r ¼ 0.46, Po0.001) in Caucasian men, while a weak association was evident with ADMA (r ¼ 0.22, P ¼ 0.013) in African men. When additional adjustments for g-Glutamyl transferase were made, the association with ADMA strengthened in the African men (r ¼ 0.27, P ¼ 0.003) and the relationship with SDMA became significant (r ¼ 0.20, P ¼ 0.03). Adjusting additionally for serum cotinine did not influence the significance of the L-arginine --SDMA association, but the association of L-arginine with ADMA was strengthened slightly (r ¼ 0.23, P ¼ 0.014). After adjusting for both g-Glutamyl transferase and cotinine simultaneously with age and BMI, the relationship of L-arginine with ADMA and SDMA strengthened further in the African men (r ¼ 0.27, P ¼ 0.003 and r ¼ 0.20, P ¼ 0.027, respectively). In Caucasian men, controlling for BMI, age, g-Glutamyl transferase and cotinine affected the associations of L-arginine with ADMA and SDMA minimally (r ¼ 0.58, Po0.001 and r ¼ 0.46, Po0.001, respectively).
Forward stepwise multiple regression analyses
The results shown in Table 4 indicate that the only similarity between the two models is the relationship between L-arginine and ADMA, where this association was stronger in the Caucasians (b ¼ 0.25 and 0.46, respectively). However, there are significant differences in the models. The variance in L-arginine is explained by serum urea and Cw in the Caucasian, but not in the African model. The correlation between Cw and L-arginine was not significant in African men. When subjects with eGFRs o90 ml min À1 per 1.73 m 2 (14% and 7% in Africans and Caucasians, respectively) were excluded from multiple regression analyses, the relationship between the L-arginine metabolites in Africans and Caucasians did not change. Other covariates included in the model were age, BMI, diastolic blood pressure, SDMA, serum creatinine, g-Glutamyl transferase and cotinine.
DISCUSSION
We measured L-arginine in African and Caucasian men to determine (1) whether there were any significant differences in serum L-arginine concentrations between the two cohorts and (2) whether these concentrations correlated with a selected group of cardiovascular risk factors. We found that L-arginine concentrations were significantly lower in African men who presented with significantly higher blood pressures. In addition, L-arginine correlated with ADMA and Cw in African men, whereas in Caucasian men L-arginine correlated with ADMA, SDMA, reactive oxygen species and serum urea. Although an association existed between L-arginine and ADMA in both African and Caucasian men, this relationship was much stronger in Caucasians and strengthened after adjusting for potential confounders. 43 --45 Our finding that African men presented with significantly higher BP and lower serum L-arginine in comparison with their Caucasian counterparts brings to mind the observations of others that an increase in diastolic blood pressure is induced by a decrease in NO in humans. 46, 47 NO induces relaxation in blood-vessel smooth muscle, thereby promoting vasodilation, whereas a reduction in the availability of NO diminishes capacity for blood vessels to dilate appropriately and favours their constriction and increased blood pressure. Abbreviations: ADMA, asymmetric dimethylarginine; Cw, arterial compliance; DBP, diastolic blood pressure; ROS, reactive oxygen species; SBP, systolic blood pressure; SDMA, symmetric dimethylarginine.
of NO. 48 Our analysis supports this observation by revealing a negative association of L-arginine with serum urea in Caucasian but not African men. The differences in L-arginine metabolism between these groups warrant tentative speculation on potential contributing factors in the light of relevant studies by other researchers. The intracellular enzyme arginase, which hydrolyses L-arginine to ornithine and urea has been shown to correlate inversely with serum L-arginine levels in some pathological conditions, 49, 50 reducing L-arginine available to NO synthase for NO production. Chandra et al. 51 have shown that when bovine aortic endothelial cells are exposed to oxidative species (for example, ONOO À ), arginase generation is enhanced significantly. Although elevated serum arginase levels may be pertinent to our study, we are cautious when extrapolating conclusions from in vitro results, particularly where oxidative species may be generated in non-physiological concentrations, to relevant in vivo studies. In addition, in nonpathological conditions, it is unusual for an intracellular enzyme, such as arginase, to leak into serum, as may occur in asthma or pulmonary hypertension; 49, 50 conditions not observed in our participants. Notwithstanding these considerations, however, our future studies will include serum arginase assays to determine whether elevated arginase may be a contributing factor.
Potentially, L-arginine and NO metabolism may be affected by severe chronic kidney disease. Skeletal muscle hypotrophy during the late stages of chronic kidney disease may release into the blood, amino acids and ureamic toxins, which in cultured endothelial cells inhibit L-arginine transport, 52 thereby elevating L-arginine levels. 53 This has not yet been confirmed in humans. In our study, the average eGFR for a minority of participants was slightly below normal without any indication of kidney disease. eGFRs demonstrated that the kidney function of most participants (86% and 94% of Africans and Caucasians, respectively) were well within the normal range and indicated that serum L-arginine was not influenced by chronic kidney disease.
Serum urea concentrations were greater in Caucasians. Our results are in agreement with reports that L-arginine is metabolized to urea in the liver via the urea cycle 54 --56 in that we found an inverse relationship (simple correlation) between Larginine and urea. However, this was significant only in Caucasian men. Although the partial correlation of L-arginine with urea was not strong, it differed between Caucasian and African men. This may reflect a difference in the fate of some of the arginine available in African men, possibly the consequence of different diets in each cohort. 57 These observations suggest that the urea cycle is differentially applied in Caucasian and African men.
In general, stronger relationships of L-arginine with ADMA and SDMA suggest a tighter regulation of NO. In Caucasian men, the association of ADMA with L-arginine was considerably stronger than that in African men, after adjustments for confounding risk factors (partial correlations). Moreover, throughout our analytical procedures (Tables 2 --4) , the L-arginine --SDMA association was not significant in the Africans, whereas in the Caucasian men this association was significant in all but the multiple regression analyses (Table 4) . L-arginine has been reported to enhance kidney function, including the excretion of urea, via the generation of NO. 48 This is supported by our observation in Caucasian males of a significant negative linear relationship (single and partial correlations) of urea with L-arginine. In contrast, a weaker association of L-arginine with ADMA (partial regression) in African men, compared with that in Caucasians, and no significant association with SDMA may indicate a reduced regulation of NO production in these Africans. We were unable to detect a significant relationship of L-arginine with urea in African men, which may indicate that L-arginine does not influence urea production in this group as it does in Caucasian men. As we have no further evidence to support this, and considering that serum urea levels are also dependent on the GFR, it is also possible that there is another explanation for our findings.
We are not the first to focus on indicators of L-arginine in relation to ethnicity. Sydow et al. 58 demonstrated that ADMA concentrations varied greatly in different ethnic groups although ADMA concentrations were similar in the two groups we observed. The roles of ADMA and SDMA were shown to be different in Africans and Caucasians. 59 However, our study is the first to investigate ethnic differences in the association of L-arginine and indicators of its metabolism with a panel of cardiovascular risk factors. We were unable to determine whether the differences found could be environmentally induced or may be imposed genetically, as occurs with differences in salt sensitivity and the renin --aldosterone pathway in Africans and Caucasians. 60 It is also possible that the differences are imposed by both environmental (for exampler, diet) and genetic causes. For example, our results suggest that alcohol and tobacco use influence the association of L-arginine with ADMA and SDMA, both inhibitors of L-arginine metabolism, considerably in African but not Caucasian men. However, this difference may reflect a lower alcohol intake and tobacco use in the Caucasians. The socioeconomic status of our African sample was significantly lower than that of the Caucasians, which may have contributed to differential alchohol and tobacco use in these groups. Although increased availability of L-arginine favours NO production, the generation of NO is also regulated by mechanisms involving ADMA, SDMA and other factors. The results of our analysis are consistent with previously described interactions of these mechanisms in an epidemiological context. 19, 29, 33, 58, 59 In addition, our results contribute to an understanding of the metabolic role of L-arginine in the differential prevalence of hypertension in Africans and Caucasians.
Study limitations
Our study is exploratory with a view to identify areas of further investigation. It is limited by its cross-sectional design in that our measurements and analyses have not conclusively identified causes underlying the differences we detected between African and Caucasian men. It did not exclude the possibility of increased serum arginase levels contributing to the differences between the two groups in L-arginine levels. The socioeconomic status between the African and Caucasian individuals who volunteered to participate in the study was different. However, HIV-infected individuals and diabetics were excluded to improve comparability in respect of traditional cardiovascular risk factors.
In conclusion, we found significantly lower levels of L-arginine in African versus Caucasian men and also found that the association between L-arginine and its dimethyl derivatives, particularly ADMA, was considerably weaker in African men in comparison with corresponding Caucasians. In addition, L-arginine correlated with serum urea only in the Caucasian group. These findings suggest (1) differential utilization of L-arginine, the primary source of circulating NO, in the two groups and (2) that further investigation of these differences in the status of L-arginine, and its metabolites, is potentially useful in developing a strategy to improve cardiovascular health in African men.
